Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity

Jian Xu1, Rong-Jian Liu1, Shaylyn Fahey1

  • 1Department of Psychiatry (Xu, Liu, Fahey, Frick, Duman, Williams, Pittenger), Child Study Center (Leckman, Vaccarino, Pittenger), Department of Pediatrics (Leckman), and Department of Neuroscience (Vaccarino), Yale University School of Medicine, New Haven, Conn.; Hunter James Kelly Research Institute, University at Buffalo, State University of New York, Buffalo (Frick); Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School (Williams), Boston; Pediatrics and Developmental Neuroscience Branch, NIMH, Bethesda, Md. (Swedo); PANDAS Physicians Network (Swedo); and Interdepartmental Neuroscience Program, Yale University, New Haven, Conn. (Pittenger).

Insights

Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) involve IgG antibodies targeting striatal cholinergic interneurons (CINs), leading to rapid-onset OCD symptoms. Treatment reducing this antibody binding correlates with symptom improvement.

Area of Science:

  • Neuroscience
  • Immunology
  • Pediatric Psychiatry

Background:

  • Pediatric obsessive-compulsive disorder (OCD) can emerge rapidly, sometimes post-infection, a condition termed PANDAS.
  • PANDAS is hypothesized to involve autoimmune responses targeting brain antigens, potentially affecting striatal cholinergic interneurons (CINs).
  • Previous studies suggest IgG from PANDAS patients binds to CINs, implicating them in tic disorders and repetitive behaviors.

Purpose of the Study:

  • To replicate and extend findings on PANDAS antibodies targeting CINs.
  • To investigate the cellular effects of PANDAS antibodies on CINs.
  • To correlate antibody binding with symptom severity and treatment response.

Main Methods:

  • Ex vivo analysis of IgG binding to human and mouse brain slices incubated with serum from PANDAS patients and controls.
  • Correlation of IgG binding with clinical symptom measures.
  • Assessment of neural activity in mouse brain slices using molecular and electrophysiological markers after serum incubation.

Main Results:

  • IgG from PANDAS patients consistently bound to CINs across three cohorts, unlike controls.
  • Post-treatment (IVIG) serum showed reduced IgG binding to CINs, correlating with symptom improvement.
  • Baseline PANDAS sera decreased striatal CIN activity and altered their electrophysiology in mouse slices.

Conclusions:

  • Striatal CINs are a critical cellular target in PANDAS, contributing to rapid-onset OCD pathophysiology.
  • These findings may extend to other related neurological or psychiatric conditions.
  • Targeting CINs could be a therapeutic strategy for PANDAS and similar disorders.
Abstract

Related Concept Videos